Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GH Guardant Health Inc.

Post-Mkt 12-11 16:57:49 EST

101.38

-1.24

-1.21%

盘后101.50

+0.12+0.12%

16:43 EST

High104.37	Low100.21	Vol1.17M
Open104.36	D1 Closing102.62	Amplitude4.05%
Mkt Cap13.12B	Tradable Cap12.57B	Total Shares129.37M
T/O119.12M	T/O Rate0.95%	Tradable Shares124.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":101.38,"timestamp":1765486800000,"preClose":102.62,"halted":0,"volume":1172825,"hourTrading":{"tag":"盘后","latestPrice":101.5,"preClose":101.38,"latestTime":"16:43 EST","volume":51500,"amount":5221074.635,"timestamp":1765489398607},"delay":0,"floatShares":124000000,"shares":129374422,"eps":-3.212374,"marketStatus":"Post-Mkt","change":-1.24,"latestTime":"12-11 16:57:49 EST","open":104.36,"high":104.3699,"low":100.21,"amount":119124452.15595,"amplitude":0.040537,"askPrice":103.39,"askSize":19,"bidPrice":101.5,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-3.212374,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765501200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":102.62,"preHourTrading":{"tag":"盘前","latestPrice":104.8,"preClose":102.62,"latestTime":"09:28 EST","volume":73,"amount":7587.27982,"timestamp":1765463281090},"postHourTrading":{"tag":"盘后","latestPrice":101.5,"preClose":101.38,"latestTime":"16:43 EST","volume":51500,"amount":5221074.635,"timestamp":1765489398607},"volumeRatio":0.538012,"impliedVol":0.683,"impliedVolPercentile":0.74},"requestUrl":"/m/hq/s/GH/wiki","defaultTab":"wiki","newsList":[{"id":"2590413355","title":"Guardant Health Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2590413355","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590413355?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:19","pubTimestamp":1765487940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 11, 2025 16:19 ET (21:19 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","GH","BK4551","BK4588","BK4196"],"gpt_icon":0},{"id":"2590165395","title":"Guardant Health Partners with Trial Library to Expand Access to Cancer Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2590165395","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590165395?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458330,"startTime":"0","endTime":"0","summary":"Guardant Health Inc., a leading precision oncology company, has announced a strategic collaboration with Trial Library, an AI technology company focused on expanding access to oncology clinical trials. The partnership aims to increase equitable access to cancer clinical trials across the United States by integrating Guardant Health's genomic data with Trial Library's AI-powered patient matching and navigation platform. This initiative seeks to streamline the identification, referral, and enrollment of diverse and underserved patient populations into precision oncology clinical trials, helping providers offer new treatment opportunities and improving participation rates in cancer research.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDLC5Ydv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","GH","BK4196","BK4588","BK4551"],"gpt_icon":0},{"id":"2590165935","title":"Guardant Health Announces Collaboration With Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2590165935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590165935?lang=en_us&edition=fundamental","pubTime":"2025-12-11 21:05","pubTimestamp":1765458300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nTUA3WBCJD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","BK4588","GH","BK4585","BK4196","BK4551"],"gpt_icon":0},{"id":"2590590987","title":"We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2590590987","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590590987?lang=en_us&edition=fundamental","pubTime":"2025-12-11 18:25","pubTimestamp":1765448733,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/we-think-gh-research-nasdaqghrs-can-easily-afford-to-drive-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/we-think-gh-research-nasdaqghrs-can-easily-afford-to-drive-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":[".IXIC","BK4585","NQmain","BK4551","PSQ","BK4588","TQQQ","BK4539","NVIW.SI","TSYW.SI","GHRS","SQQQ","QID","GH","MNQmain","BK4196","BK4535","QLD","USJW.SI","BK4007","USAW.SI"],"gpt_icon":1},{"id":"2590568750","title":"Guardant Health CIO Kumud Kalia Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590568750","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590568750?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:33","pubTimestamp":1765420397,"startTime":"0","endTime":"0","summary":"Kumud Kalia, Chief Information Officer of Guardant Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL4bGmcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","BK4585","BK4588","BK4196","GH"],"gpt_icon":0},{"id":"2590156875","title":"Director Manuel Hidalgo Medina Reports Disposal of Guardant Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590156875","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590156875?lang=en_us&edition=fundamental","pubTime":"2025-12-11 10:32","pubTimestamp":1765420366,"startTime":"0","endTime":"0","summary":"Manuel Hidalgo Medina, Director at Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 10, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"b038ff687efe36210ac6c40aceddb1eb","theme_name":"🔥TrendingNo.30 · Wave Life Sciences and Guardant Health Executives Report Disposal of Common Shares on December 10, 2025","theme_type":2,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nNDL1vN4ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Manuel Hidalgo Medina Reports Disposal of Guardant Health Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4196","BK4535","BK4588","BK4585","GH"],"gpt_icon":0},{"id":"2590349567","title":"Guardant Health Launches In-House Liquid Biopsy Testing Service at Policlinico Gemelli in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349567","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349567?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:05","pubTimestamp":1765285515,"startTime":"0","endTime":"0","summary":"Guardant Health Inc., a leading precision oncology company, has launched FPG 360, an in-house liquid biopsy testing service at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Rome, Italy. This expansion marks one of the first dedicated liquid biopsy testing facilities within a hospital system in Italy and is intended to provide local cancer patients with access to comprehensive genomic profiling without the need to send samples abroad. The partnership supports both routine care and clinical research, and builds on Guardant Health's previous collaborations with top-tier European hospitals, further expanding access to precision oncology diagnostics across the region.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guard","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL1vkGdy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4196","BK4551","GH","BK4585","BK4588"],"gpt_icon":0},{"id":"2590395538","title":"Guardant Health Chief Commercial Officer Chris Freeman Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590395538","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590395538?lang=en_us&edition=fundamental","pubTime":"2025-12-09 10:38","pubTimestamp":1765247895,"startTime":"0","endTime":"0","summary":"Chris Freeman, Chief Commercial Officer of Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL5yRmF9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","BK4535","GH","BK4588","BK4551"],"gpt_icon":0},{"id":"2589919897","title":"Guardant Health Unveils Data on Liquid Biopsy Tests for Breast Cancer at SABCS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589919897","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589919897?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:05","pubTimestamp":1764939921,"startTime":"0","endTime":"0","summary":"Guardant Health Inc. announced that it will present 14 abstracts at the 2025 San Antonio Breast Cancer Symposium, taking place December 9-12, 2025. The presentations will include results from studies utilizing Guardant Reveal, the company's tissue-free test for detecting minimal residual disease , and Guardant360 Liquid, a comprehensive multiomic profiling test. Highlights include data demonstrating the clinical utility of Guardant Reveal in predicting outcomes for patients with early-stage HER2-positive breast cancer, with early circulating tumor DNA  clearance during treatment associated with improved outcomes. The company's findings underscore the potential of blood-based, non-invasive testing to inform treatment selection and patient management across early and metastatic breast cancer settings. Results from these studies will be presented at the upcoming symposium.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL7RxRJS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4551","BK4535","BK4196","GH"],"gpt_icon":0},{"id":"2588050075","title":"Guardant Health Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2588050075","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588050075?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:50","pubTimestamp":1764697800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 12:50 ET (17:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","BK4535","BK4196","BK4585","BK4551"],"gpt_icon":0},{"id":"2588803778","title":"Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2588803778","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588803778?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:48","pubTimestamp":1764676128,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $101.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4535","BK4551","BK4585","GH","BK4196"],"gpt_icon":0},{"id":"2586950744","title":"GH Research to Present Promising Results on GH001 at ACNP 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2586950744","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586950744?lang=en_us&edition=fundamental","pubTime":"2025-11-24 23:48","pubTimestamp":1763999294,"startTime":"0","endTime":"0","summary":"GH Research ( ($GHRS) ) has provided an update. GH Research PLC announced its acceptance to present at the 64th American College of Neuropsychophar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gh-research-to-present-promising-results-on-gh001-at-acnp-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gh-research-to-present-promising-results-on-gh001-at-acnp-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4551","GH","BK4588","BK4196","BK4535"],"gpt_icon":0},{"id":"2585160984","title":"Guardant Health Director Tariq Musa Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2585160984","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585160984?lang=en_us&edition=fundamental","pubTime":"2025-11-21 10:28","pubTimestamp":1763692083,"startTime":"0","endTime":"0","summary":"Tariq Musa, Director at Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nNDLmSYzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","BK4196","BK4588","BK4551","BK4535"],"gpt_icon":0},{"id":"2585157530","title":"These 15 stocks are still showing momentum - and a market-beating edge","url":"https://stock-news.laohu8.com/highlight/detail?id=2585157530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585157530?lang=en_us&edition=fundamental","pubTime":"2025-11-21 04:45","pubTimestamp":1763671500,"startTime":"0","endTime":"0","summary":"'Big mo' stock strategies have lost their advantage, but these companies display relative strength. When it comes to following momentum strategies in the stock market, all are based on the same basic premise: Stocks that have recently performed the best are likely to continue performing well for a while longer. The difference between the various strategies boils down to how to put that premise into practice.The answer that has academia's seal of approval is to define momentum over the period from 12 months previously to one month previously, and to reform the portfolio on a monthly basis.Over 150 years of U.S. stock-market history, this approach has handily beaten the market average. But over the past couple of decades, momentum strategies have weakened.The study's authors obtained data showing not only the web pages that a large sample of investors focused on before buying or selling stocks, but how long they spent on each of tho","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4168","LU1989764664.SGD","BK4524","INSM","BK4141","IE0009354923.USD","W","LU0053671581.USD","GH","LU2290526834.HKD","LU0444973449.USD","LU2360107168.USD","SNDK","LU1861220033.SGD","BE","WBD","LU2264538146.SGD","BK4108","CIEN","LU0823414551.USD","SATS","LU0205194284.USD","LU1988902786.USD","LU0477156953.USD","BK4585","WDC","RNA","LU0006061336.USD","BK4020","LU0240878834.USD","BK4139","LU0205193047.USD","BK4512","LU0823421416.USD","LU0889565916.HKD","BK4170","LU0505663152.USD","LU0154245673.USD","LU0106261612.USD","MP","LU0154245756.USD","IE00BD6J9T35.USD","BK4539","LU1235294995.USD","LU0823414478.USD","OKLO","LU0320765992.SGD","CRDO","BK4505","LU0154236417.USD"],"gpt_icon":1},{"id":"2584252379","title":"Guardant Health Announces Proposed $300.0 Million Offering Of Convertible Senior Notes Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2584252379","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584252379?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:33","pubTimestamp":1763569994,"startTime":"0","endTime":"0","summary":"Guardant Health Inc ::*GUARDANT HEALTH ANNOUNCES PROPOSED $300.0 MILLION OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2033  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 04-NOV-202521:38:00.133 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD2nk68G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GH","BK4196","BK4588","BK4551","BK4535"],"gpt_icon":0},{"id":"2584957221","title":"6 Healthcare Stocks With Strong Upward Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957221","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584957221?lang=en_us&edition=fundamental","pubTime":"2025-11-19 01:59","pubTimestamp":1763488740,"startTime":"0","endTime":"0","summary":"Out with the old , in with the new . After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.The rotation has technical and fundamental tailwinds too, as healthcare earnings have been strong and several stocks are breaking out into new uptrends.Today, we'll look at six stocks in the healthcare sector that have been surging higher for a variety of reasons and score well on Benzinga’s Momentum rankings.Benzinga Edge helps you stay ahead with real-time data, stock rankings, and exclusive analyst insights. Spot opportunity before the headlines hit and secure full access for 65% off.Now let's jump to the biotech sector with Abivax , a French pharmaceutical developer focused on chronic inflammatory diseases. The compa","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["TQQQ","BK4196","LU0154236417.USD","TSYW.SI","SQQQ","BK4121","LU1267930490.SGD","PSQ","LU0128525689.USD","LU2065171311.SGD","CAH","LU1880398554.USD","MEDP","BK4139","NVIW.SI","XBI","QID","LU0006061336.USD",".IXIC","LU1571399168.USD","LU2065169927.USD","LU0310800965.SGD","LU0072461881.USD","LABU","LU2065171402.SGD","WGS","MNQmain","LU2065170008.USD","BK4588","USJW.SI","SMA","HCSG","LU0889566641.SGD","XLV","USAW.SI","BK4137","GH","BK4175","BK4581","ELAN","LU1880398471.USD","QLD","LU1941712348.USD","BK4551","LU0310799852.SGD","BK4535","NQmain","LU0211328371.USD","ABVX"],"gpt_icon":1},{"id":"2583030776","title":"Don't Ignore The Insider Selling In Guardant Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2583030776","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583030776?lang=en_us&edition=fundamental","pubTime":"2025-11-13 02:26","pubTimestamp":1762971985,"startTime":"0","endTime":"0","summary":"Some Guardant Health, Inc. ( NASDAQ:GH ) shareholders may be a little concerned to see that the Chief Legal Officer...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/dont-ignore-the-insider-selling-in-guardant-health","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/dont-ignore-the-insider-selling-in-guardant-health","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GH","BK4585","BK4588","BK4196","BK4535","BK4551"],"gpt_icon":0},{"id":"2582790093","title":"Guardant Health Leads 34-Member Consortium to Set Global Standard for Exabyte-Scale Data Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2582790093","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582790093?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:05","pubTimestamp":1762952749,"startTime":"0","endTime":"0","summary":"Guardant Health Inc. has announced the launch of the Single Namespace Working Group , a 34-member cross-industry consortium aimed at creating an interoperable data standard for exabyte-scale data access. The consortium includes leading technology, healthcare, and research institutions such as NetApp, Seagate, IBM, DDN, Genentech, Hammerspace, Weka, and Lawrence Livermore National Laboratory. Together, the group has developed the first open standard for managing massive, distributed datasets, enabling seamless, AI-ready infrastructure across various platforms. The SNS is now transitioning to the international standards body OASIS, which will publish the open specifications to promote global scalability, interoperability, and efficiency for data access.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shoul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDLc1sbLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4612","LU0203345920.USD","IBM","BK4579","BK4551","LU1883839398.USD","LU0868494617.USD","BK4538","LU1894683348.USD","LU0321505868.SGD","BK4575","LU0942090050.USD","LU1674673428.USD","BK4543","LU1670627923.USD","LU1880398554.USD","BK4170","BK4535","LU1880398471.USD","IE00B19Z9P08.USD","BK4588","GH","BK4534","BK4533","LU0203347892.USD","LU0321505439.SGD","LU1430594728.SGD","LU1585245621.USD","LU0868494708.USD","LU1778281490.HKD","BK4602","BK4196","LU1670628061.USD","BK4585","SG9999001440.SGD","IE00B19Z9Z06.USD","IE00B894F039.SGD","BK4512","NTAP","LU1674673691.USD","LU1894683264.USD","BK4134"],"gpt_icon":1},{"id":"2582848023","title":"Guardant Health Director Manuel Hidalgo Medina Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582848023","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582848023?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:18","pubTimestamp":1762820332,"startTime":"0","endTime":"0","summary":"Manuel Hidalgo Medina, Director at Guardant Health Inc., reported a disposal of common shares of Guardant Health Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL3N08jJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Manuel Hidalgo Medina Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","GH","BK4196","BK4588","BK4551"],"gpt_icon":0},{"id":"2582880645","title":"GH Research Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2582880645","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582880645?lang=en_us&edition=fundamental","pubTime":"2025-11-11 01:20","pubTimestamp":1762795200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GHRS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 12:20 ET (17:20 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0315},{"period":"1month","weight":0.048},{"period":"3month","weight":0.8068},{"period":"6month","weight":1.082},{"period":"1year","weight":1.8883},{"period":"ytd","weight":2.3591}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.064605},{"month":2,"riseRate":0.285714,"avgChangeRate":0.06426},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.023739},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.017651},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.065945}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Guardant Health Inc.(GH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}